Anti-Müllerian hormone (AMH) has become one of the most widely ordered tests in reproductive medicine, and for good reason — it provides more consistent, actionable information about ovarian reserve than any other blood marker available. At the same time, it is frequently misunderstood, overinterpreted, and used in ways that can cause unnecessary alarm.
This guide explains what AMH actually measures, how to interpret results across different ages, what it can and cannot tell you about your fertility, and what to do if your number comes back low — or high.
What AMH Measures
AMH is a protein hormone produced by granulosa cells in small antral and pre-antral follicles — the immature follicles that make up your recruitable egg pool. AMH levels directly reflect the number of these follicles remaining. Because AMH is secreted continuously from this pool, it serves as a biological proxy for the size of your remaining ovarian reserve.
Why AMH is particularly useful:
- It can be measured on any day of the menstrual cycle (unlike FSH and estradiol, which must be measured on day 2–4)
- It varies minimally between cycles in the same individual (unlike FSH, which fluctuates)
- It declines gradually and predictably with age, making it a good longitudinal marker
- It is detectable at very low levels with modern assays, providing information even in women approaching menopause
What AMH does NOT measure:
- Egg quality (aneuploidy rate, genetic integrity) — this is primarily determined by age
- Ability to conceive naturally in a given cycle — ovarian reserve affects quantity, not the quality of the individual egg that ovulates
- Time to menopause with precision — it predicts decline trajectory, not an exact date
How the AMH Test Works
A standard blood draw is all that is required. No fasting is needed. The sample is analyzed by immunoassay at a clinical laboratory. Two major assay platforms exist — the Beckman Coulter Access AMH assay and the Ansh Labs picoAMH assay — and results are not fully interchangeable between them. Understanding which assay your lab uses is relevant for interpreting borderline results.
Results are typically reported in nanograms per milliliter (ng/mL) in the US, or picomoles per liter (pmol/L) in countries using SI units. The conversion is: 1 ng/mL ≈ 7.14 pmol/L.
AMH Reference Ranges by Age
AMH levels are most meaningful in the context of age. A "low" AMH at age 44 may be entirely expected; the same level at age 28 would be concerning.
The following ranges reflect approximate median and reference values from published normative studies (Broer et al., AMH data for the general population):
| Age Range | Median AMH (ng/mL) | Low (5th percentile) | High (95th percentile) |
|---|---|---|---|
| 20–24 | 3.8 | 1.4 | 8.9 |
| 25–29 | 3.2 | 1.2 | 7.5 |
| 30–34 | 2.5 | 0.8 | 6.0 |
| 35–39 | 1.6 | 0.4 | 4.4 |
| 40–44 | 0.7 | 0.1 | 2.5 |
| 45–49 | 0.2 | <0.1 | 1.0 |
Values may vary slightly by laboratory and assay. These ranges represent large population samples and individual variation is substantial.
Practical interpretation thresholds:
| AMH Level | Interpretation |
|---|---|
| >3.5 ng/mL | High reserve; may indicate PCOS in appropriate clinical context |
| 1.0–3.5 ng/mL | Normal range for reproductive-age women |
| 0.5–1.0 ng/mL | Low-normal; may reflect early decline in reserve |
| <0.5 ng/mL | Diminished ovarian reserve (DOR) |
| <0.1 ng/mL | Severely diminished; near-undetectable |
What Low AMH Means (and Doesn't Mean)
Receiving a low AMH result is alarming for most patients — but it is important to understand what it does and does not mean.
What low AMH does mean:
- Your ovarian reserve is lower than expected for your age
- You are likely to produce fewer eggs in response to IVF stimulation medications
- Your reproductive window may be shorter than average (earlier decline toward menopause)
- You may have more difficulty conceiving than women with age-appropriate reserve
What low AMH does NOT mean:
- You cannot conceive naturally — natural conception requires only one good egg per cycle, and AMH does not predict whether the egg that ovulates in any given month is genetically normal
- Your eggs are poor quality — egg quality is primarily driven by age, not AMH level
- IVF will fail — low AMH predicts the number of eggs retrieved, not the live birth rate per embryo transferred
- You should give up trying to conceive
The Broer et al. data consistently show that while low AMH strongly predicts poor response in IVF (few eggs retrieved), it is a weaker predictor of clinical pregnancy rate per embryo transfer — meaning that when eggs are obtained and embryos created, low AMH does not independently lower the probability of that embryo implanting.
The ASRM AMH committee opinion emphasizes this distinction: AMH predicts ovarian response, not fertility directly. A 30-year-old woman with AMH of 0.4 ng/mL may have fewer eggs to work with in IVF, but the eggs she produces may still be high quality, and natural conception remains possible.
What High AMH Means
High AMH (>3.5–4.0 ng/mL) indicates a large antral follicle pool. This is generally favorable for fertility treatment but also raises the question of polycystic ovary syndrome (PCOS).
Women with PCOS typically have AMH levels 2–3 times higher than age-matched controls, due to the large number of small antral follicles characteristic of polycystic ovaries. AMH is not a diagnostic test for PCOS (diagnosis requires the Rotterdam criteria), but a very high AMH in a woman with irregular cycles and other PCOS features is consistent with the diagnosis.
High AMH also predicts ovarian hyperstimulation syndrome (OHSS) risk in IVF. Women with AMH >3.5–4.0 ng/mL should be managed with OHSS-prevention protocols:
- GnRH antagonist protocol (rather than long lupron)
- Lower starting FSH doses
- GnRH agonist trigger (instead of hCG) when possible
- Freeze-all strategy to eliminate fresh transfer in high-risk cycles
- Cabergoline or other medical prophylaxis
Exploring Conception Options?
Whether your AMH is low, normal, or high, understanding the full landscape of fertility options helps ensure you're making the most informed decision for your situation.
MakeAMom makes reusable at-home insemination kits for couples and individuals trying to conceive at home: the CryoBaby for frozen or low-volume sperm, the Impregnator for low-motility sperm, and the BabyMaker for those with sensitivities. Kits ship discreetly and are designed for use without a clinic visit.
Explore home insemination kits at MakeAMom →
AMH vs. Day-3 FSH: How They Compare
Both AMH and day-3 FSH measure ovarian reserve, but they provide different types of information:
| Feature | AMH | Day-3 FSH |
|---|---|---|
| Timing of test | Any cycle day | Day 2–4 only |
| Cycle-to-cycle variability | Low | High |
| Direction with declining reserve | Falls | Rises |
| Sensitivity for low reserve | High | Moderate |
| Predicts ovarian response | Strong | Moderate |
| Influenced by OCP use | Yes (may lower) | No |
Day-3 FSH has been used for decades and remains part of the standard reserve assessment. Its main limitation is variability — a single normal FSH does not rule out DOR if AMH is low, while a single elevated FSH on a day when estradiol was also elevated may be a false positive. FSH is most reliable when interpreted together with day-3 estradiol.
Most reproductive endocrinologists now consider AMH the primary ovarian reserve marker, with FSH and AFC as complementary measures.
AMH and Antral Follicle Count: Complementary Information
Antral follicle count (AFC) — the number of small follicles visible on transvaginal ultrasound at the start of a cycle — is the most direct anatomical measure of ovarian reserve. It correlates strongly with AMH (both reflect the same underlying follicle pool) and with ovarian response to stimulation.
In the ASRM guidance and Broer et al. data:
- AMH and AFC are roughly equivalent as predictors of ovarian response
- AMH has the advantage of being measurable on any cycle day
- AFC requires experienced sonographers and is more variable between operators
When AMH and AFC are discordant (e.g., low AMH but normal AFC), the AFC is often considered more reliable because it directly counts follicles rather than measuring a secondary marker.
Does AMH Predict Natural Fertility?
This is one of the most important and frequently misunderstood questions. Several observational studies have examined AMH and time-to-pregnancy in women trying to conceive naturally:
- Steiner et al. (2017, JAMA): Among women aged 30–44 trying to conceive naturally, AMH did not predict the probability of conception per cycle. Women with low AMH conceived at similar rates to women with normal AMH within the 12-month study window.
- Broer et al.: Confirmed that AMH is a strong predictor of ovarian response in IVF but a much weaker predictor of live birth per cycle in natural conception.
The implication: a low AMH at age 32 does not mean you will have trouble getting pregnant naturally in the near term. What it does mean is that you may have fewer chances over time, and that if IVF is ultimately needed, you may have a lower egg yield.
AMH and Egg Freezing: When to Test and When to Act
AMH is frequently used to guide egg freezing decisions. If you are considering fertility preservation by egg freezing, AMH testing — ideally combined with AFC — is strongly recommended before starting.
Key considerations:
- Women with AMH <1.0 ng/mL may produce fewer eggs per retrieval cycle and may need multiple cycles to bank an adequate number.
- Expected egg yield can be estimated: roughly 8–10 eggs per retrieval in normal responders, declining to 2–5 per cycle in low responders.
- The number of eggs needed for a reasonable chance at live birth depends on age (more eggs needed at older ages due to higher aneuploidy rates).
- Our egg freezing and vitrification guide covers expected egg numbers and what they translate to in terms of live birth probability.
Insurance Coverage for AMH Testing
AMH testing is not uniformly covered by health insurance. Coverage varies by plan and state. Key points:
- AMH testing ordered as part of an infertility evaluation is covered by some plans but not others.
- Direct-to-consumer AMH tests (offered by companies like Everlywell, LetsGetChecked, etc.) are available without a prescription for $50–150 but provide reference ranges that may not be age-contextualized or interpreted with clinical nuance.
- If you are in a state with mandated infertility coverage, AMH is often included in required diagnostic testing.
- Many fertility clinics include AMH in initial consultation panels; ask before your visit whether this is covered by your plan.
What to Do With a Low AMH Result
Receiving a low AMH result is not a crisis — it is information. Here is a practical response framework:
- Get a complete reserve assessment. AMH alone is not the full picture. Ask for AFC and day-3 FSH/estradiol to confirm the finding.
- See a reproductive endocrinologist. A single number on a lab slip is not the same as a clinical evaluation. An REI can contextualize your result with your age, symptoms, menstrual history, and goals.
- Understand your timeline. Low AMH means your window may be shorter than average. This doesn't mean "act now regardless of your life circumstances," but it does mean "don't assume you have indefinite time."
- Consider fertility preservation consultation. If you're not ready to conceive, a consultation about egg freezing is appropriate and will not commit you to anything. Women whose AMH is very low may meet criteria for diminished ovarian reserve — the condition hub explains how this affects treatment options.
- Avoid panic. Natural conception is possible with low AMH. Many women with AMH <0.5 ng/mL have conceived naturally and via IVF.
Frequently Asked Questions
Q: Can AMH be tested on any day of the menstrual cycle? A: Yes. Unlike FSH and estradiol, which must be measured on cycle days 2–4, AMH can be measured on any cycle day because it is secreted continuously from antral follicles and varies minimally between cycles in the same individual. This makes it a more convenient and reliable marker than FSH for routine ovarian reserve assessment.
Q: If my AMH is low, does that mean I cannot get pregnant naturally? A: No. A landmark 2017 JAMA study by Steiner et al. found that among women aged 30–44 trying to conceive naturally, low AMH did not predict lower probability of conception per cycle compared to women with normal AMH. A low AMH means your reproductive window may be shorter and IVF may yield fewer eggs, but it does not mean natural conception is impossible.
Q: What does a high AMH level indicate? A: High AMH (greater than 3.5–4.0 ng/mL) indicates a large antral follicle pool, which is generally favorable for fertility treatment. However, women with PCOS typically have AMH levels 2–3 times higher than age-matched controls. High AMH also predicts elevated OHSS risk in IVF, requiring careful stimulation planning including lower FSH doses and GnRH agonist trigger when possible.
Q: How does AMH compare to the antral follicle count (AFC) as a test? A: Both reflect the same underlying follicle pool and are highly correlated. AMH has the advantage of being measurable on any cycle day without an ultrasound appointment, while AFC provides direct visual confirmation and is considered more reliable when the two tests are discordant. Most reproductive endocrinologists use both together for the most complete picture of reserve.
Q: What should I do if my AMH result comes back low? A: A low AMH is not a crisis — it is information. The recommended response is to confirm the finding with AFC and day-3 FSH, see a reproductive endocrinologist for context-specific counseling, understand your realistic timeline, and consider a fertility preservation consultation. Many women with AMH below 0.5 ng/mL have conceived both naturally and through IVF.
Key Takeaways
- AMH is the best blood marker of ovarian reserve because it is stable across the menstrual cycle and declines predictably with age.
- Low AMH predicts poor response in IVF (fewer eggs retrieved) more reliably than it predicts natural fertility.
- High AMH is associated with PCOS and elevated OHSS risk in IVF.
- AMH should be interpreted in the context of age, AFC, and FSH — not in isolation.
- A low AMH does not mean you cannot conceive naturally; it means your reproductive window may be shorter and that IVF, if needed, may produce fewer eggs.
References
- American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103(3):e9–e17.
- Broer SL, et al. The role of antimüllerian hormone as ovarian reserve marker in prediction of ovarian response and pregnancy in IVF. Hum Reprod Update. 2009;15(3):255–266.
- Steiner AZ, et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318(14):1367–1376.
- Nelson SM, et al. Anti-Müllerian hormone-based dosing of FSH for assisted conception. Hum Reprod. 2009;24(4):791–799.
- Dewailly D, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20(3):370–385.
